APOA1 and cardiovascular disorder: Greater HDL cholesterol efflux capacity (HDL-CEC), a measure of HDL reverse cholesterol transport functionality, associates linearly with reduced cardiovascular disease risk independently from HDL-C and of Apolipoprotein A-I (ApoA-I), the main constituent protein of HDL particles [15,16].